| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FBXW7_0007900 | Exon-Exon | chr4:153332455-153333681 | chr4:152411303-152412529 | 1227 nt | 0.3578 |
| hsa_FBXW7_0006900 | Exon-Intron | chr4:153332455-153391140 | chr4:152411303-152469988 | 250 nt | 0.2920 |
| hsa_FBXW7_0007000 | Exon-Intron | chr4:153332455-153403825 | chr4:152411303-152482673 | 250 nt | 0.3080 |
| hsa_FBXW7_0008800 | Exon-Exon | chr4:153332455-153456185 | chr4:152411303-152535033 | 663 nt | 0.4766 |
| hsa_FBXW7_0007100 | Exon-Exon | chr4:153332455-153456393 | chr4:152411303-152535241 | 871 nt | 0.5086 |
| hsa_FBXW7_0012400 | Intron-Intron | chr4:153391093-153403825 | chr4:152469941-152482673 | 250 nt | 0.2480 |
| hsa_FBXW7_0014300 | Exon-Exon | chr4:153456093-153456185 | chr4:152534941-152535033 | 93 nt | 0.6129 |
| hsa_FBXW7_0014400 | Exon-Exon | chr4:153456093-153456393 | chr4:152534941-152535241 | 301 nt | 0.6113 |
| hsa_RP11-461L13.2_0000100 | Intergenic-Exon-Intergenic | chr4:153253833-153268174 | chr4:152332681-152347022 | 132 nt | 0.5076 |
| hsa_FBXW7_0000200 | Exon-Exon | chr4:153243748-153247383 | chr4:152322596-152326231 | 991 nt | 0.4369 |
A study in human brain cancer demonstrated that the circFBXW7 functions as a tumor suppressor, where its expression inhibits cell progression, migration, and tumor formation [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. Further research confirmed its coding potential, showing the translated peptide FBXW7-185aa reduces the half-life of c-Myc and inhibits cell cycle progression [Sema Misir et al. DOI:10.1038/s41418-022-00948-7]. The peptide FBXW7-185aa, which originates from the circFBXW7, inhibits cell cycle progression [Misir et al. DOI:10.1038/s41418-022-00948-7].